Yemen

in page functions
[French]
Yemen
Total population (2018) 28,758,258
Birth cohort (2018) 870,107
Surviving Infants (surviving to 1 year per year, 2018) 828,275
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 34/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 42/1000
World Bank Index, IDA (2015) 2.61
Gross Nation Income (per capita US$, 2015) 1,140
Co-financing group (2018) Preparatory transition
No. of districts/territories (2017) 333

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Yemen

Type of support

Approvals

2001-2022 (US$)
(22 Aug 2018)

Commitments

2001-2022 (US$)
(22 Aug 2018)

Disbursements

2000-2018 (US$)
(22 Aug 2018)

% Disbursed

(22 Aug 2018)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
Total $250,567,817 $250,567,817 $242,727,513
Health system strengthening (HSS 1) $6,335,000 $6,335,000 $6,335,000 100%
Health system strengthening (HSS 2) $17,639,234 $17,639,234 $14,279,312 81%
Immunisation services support (ISS) $5,049,500 $5,049,500 $5,049,500 100%
Injection Safety Devices (NVS) $949,344 $949,344 $1,208,393 127%
Injection safety support (INS) $1,194,757 $1,194,757 $1,194,757 100%
IPV (NVS) $5,321,103 $5,321,103 $3,918,778 74%
Measles-Rubella (NVS) $8,313,136 $8,313,136 $8,313,136 100%
MR - Operational costs (OPC) $7,533,500 $7,533,500 $7,533,500 100%
Penta (NVS) $73,476,337 $73,476,337 $77,029,817 105%
Penta - campaign (NVS) $1,849,000 $1,849,000 $1,491,141 81%
Pneumo (NVS) $96,818,128 $96,818,128 $92,079,559 95%
Rotavirus (NVS) $22,640,778 $22,640,778 $21,384,320 94%
Td - campaign (NVS) $1,339,000 $1,339,000 $801,300 60%
Vaccine Introduction Grant (VIG) $2,109,000 $2,109,000 $2,109,000 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Yemen DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2017)

Grade of confidence


N/A
DTP3 - Official country estimates (2017) 83%
M:F sex ratio at birth (2018) 1.05
Household survey: DTP3 coverage for male (2012) 59.70%
Household survey: DTP3 coverage for female (2012) 59.60%
Household survey: Last DTP3 survey (2012) 60%
% districts achieving > 80% DTP3 coverage (2017) 62%
% districts achieving < 50% DTP3 coverage (2017) 11%
MCV WHO/UNICEF estimates (2017) 65%

Breakdown of support

Non-vaccine support Vaccine support
15% 85%
$36,501,069 $206,226,444

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Yemen

06 June 2018

Gavi Board meeting, 6-7 June 2018

The Gavi Board meeting was held in Geneva, Switzerland on 6-7 June 2018.

21 December 2017

2017 letter

2017: responding to global challenges

Letter from Gavi's CEO, Dr Seth Berkley.

15 June 2017

DRC: a nurse vaccinates a child

Gavi to help protect millions more children against polio

Gavi Board agrees to extend support for inactivated polio vaccine (IPV) to 2020; new policy on fragile settings, emergencies and refugees also approved.

Disclaimer: the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of Gavi, the Vaccine Alliance concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.

close icon

modal window here